NCT05412108

Brief Summary

Midline catheters (MCs) are peripheral catheters inserted into a vein in the arm above the elbow crease, with the tip in the axillary vein. As such, they do not enter the central venous circulation and are therefore not considered central venous catheters. The main complications associated with CM are accidental removal, leakage, subcutaneous diffusion and occlusion. Severe complications include deep vein thrombosis (DVT) and catheter-related bacteremia (CRB). There is very little data on the use of CMs in intensive care units (ICU). Resuscitation patients are more likely to develop severe catheter-related complications such as deep vein thrombosis and catheter-related infections. While the use of CMs in patients appears to be associated with a low risk of complications, this may not be the case in resuscitation patients. Investigator therefore proposes to conduct a prospective observational study to determine the frequency and type of complications associated with CMs when they are implanted and used in ICU. In addition, investigator will attempt to determine whether risk factors predictive of complications can be identified. In addition, this study will evaluate whether the use of CMs can reduce the duration of central venous catheter maintenance in the ICU and the risk of central venous catheter-related infections.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 17, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 31, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 9, 2022

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

July 1, 2026

Status Verified

June 1, 2026

Enrollment Period

2.9 years

First QC Date

May 31, 2022

Last Update Submit

June 30, 2026

Conditions

Keywords

Midline catheterICU Hospitalization

Outcome Measures

Primary Outcomes (1)

  • Describe the incidence of severe complications associated with the use of CMs in ICUs

    The severe complications identified will be symptomatic deep vein thrombosis, symptomatic pulmonary embolism, catheter-related infections

    From midline catheter placement to hospital discharge (up to 28 days)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients admitted to the ICU for whom an indication for placement of a MidLine catheter is identified during their ICU stay

You may qualify if:

  • ICU Hospitalization
  • Indication for MidLine catheter placement during the stay

You may not qualify if:

  • Minor or protected adult
  • Pregnant woman
  • Local contraindication to the placement of a CM
  • Local infection
  • Venous thrombosis
  • Existing arteriovenous fistula or vascular network to be protected for a fistula for chronic dialysis
  • Paralysis of the limb
  • Need for administration of contraindicated solutions on the peripheral venous route:
  • Catecholamines: Noradrenaline, adrenaline (dose greater than 0.2µg/kg/min)
  • Total parenteral nutrition
  • Glucose solutions at a concentration \>20
  • Potassium at a concentration \>0.1mEq/ml
  • Vesicants
  • Fluids with pH \<5 or \>9

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Du Mans

Le Mans, 72000, France

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2022

First Posted

June 9, 2022

Study Start

February 17, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

July 1, 2026

Record last verified: 2026-06

Locations